[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]

October 2017 - July 1883

Decade

Year

Issue

February 24, 2015, Vol 313, No. 8, Pages 771-868

In This Issue of JAMA

Highlights

Abstract Full Text
free access has audio
JAMA. 2015;313(8):771-773. doi:10.1001/jama.2014.11595
Viewpoint

Scientific Discovery and the Future of Medicine

Genomic Engineering and the Future of Medicine

Abstract Full Text
has audio
JAMA. 2015;313(8):791-792. doi:10.1001/jama.2015.287

Sharing Clinical Trial DataMaximizing Benefits, Minimizing Risk

Abstract Full Text
free access
JAMA. 2015;313(8):793-794. doi:10.1001/jama.2015.292

This Viewpoint discusses the benefits, challenges, and risks of sharing clinical trial findings and data.

Optimizing High-Risk Care Management

Abstract Full Text
JAMA. 2015;313(8):795-796. doi:10.1001/jama.2014.18171

This Viewpoint discusses the potential of high-risk care management programs that are practice-based, payer-catalyzed, and purchaser-supported to deliver better care at lower cost.

Medicare and Care CoordinationExpanding the Clinician’s Toolbox

Abstract Full Text
JAMA. 2015;313(8):797-798. doi:10.1001/jama.2014.18174

This Viewpoint aims at helping health care professionals understand the components involved with providing non–face-to-face chronic care management (CCM) to Medicare patients.

A Piece of My Mind

For What It’s Worth

Abstract Full Text
JAMA. 2015;313(8):799-800. doi:10.1001/jama.2014.15004
Editorial

Potential Hazards of Adding Nonsteroidal Anti-inflammatory Drugs to Antithrombotic Therapy After Myocardial InfarctionTime for More Than a Gut Check

Abstract Full Text
JAMA. 2015;313(8):801-802. doi:10.1001/jama.2015.0567

This Viewpoint discusses potental hazards related to the concomitant use of nonsteroidal anti-inflammatory drugs and antithrombotic therapy after myocardial infarction.

Precision Medicine to Improve the Risk and Benefit of Cancer CareGenetic Factors in Vincristine-Related Neuropathy

Abstract Full Text
JAMA. 2015;313(8):803-804. doi:10.1001/jama.2015.1086
Original Investigation

Association of NSAID Use With Risk of Bleeding and Cardiovascular Events in Patients Receiving Antithrombotic Therapy After Myocardial Infarction

Abstract Full Text
free access
JAMA. 2015;313(8):805-814. doi:10.1001/jama.2015.0809

This analysis of data from Danish administrative registries reports that among patients receiving antithrombotic therapy after myocardial infarction, use of nonsteroidal anti-inflammatory drugs was associated with increased risk of bleeding and thrombotic events.

Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia

Abstract Full Text
free access has multimedia has audio
JAMA. 2015;313(8):815-823. doi:10.1001/jama.2015.0894

This genome-wide association study performed among children with acute lymphoblastic leukemia (ALL) found that an inherited polymorphism in the promoter region of CEP72 was associated with increased risk and severity of vincristine-related peripheral neuropathy.

Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients With Anticoagulation-Related Intracerebral Hemorrhage

Abstract Full Text
free access
JAMA. 2015;313(8):824-836. doi:10.1001/jama.2015.0846

This retrospective cohort study in Germany reports on analyses of the treatment of oral anticoagulation–associated intracerebral hemorrhage and its association with rates of hematoma enlargement, ischemic and hemorrhagic events with or without resumption of oral anticoagulation, and long-term functional outcome.

Review

Glomerular Filtration Rate and Albuminuria for Detection and Staging of Acute and Chronic Kidney Disease in AdultsA Systematic Review

Abstract Full Text
has active quiz
JAMA. 2015;313(8):837-846. doi:10.1001/jama.2015.0602

This systematic review summarizes evidence supporting the use of laboratory tests for glomerular filtration rate and albuminuria to detect and stage kidney disease in adults.

From the JAMA Network

Hydroxychloroquine and the Retina

Abstract Full Text
JAMA. 2015;313(8):847-848. doi:10.1001/jama.2014.14558
JAMA Diagnostic Test Interpretation

Elevated Lactate Levels in a Non–Critically Ill Patient

Abstract Full Text
JAMA. 2015;313(8):849-850. doi:10.1001/jama.2014.14074
Research Letter

Trends in the Proportion of Patients With Lung Cancer Meeting Screening Criteria

Abstract Full Text
free access
JAMA. 2015;313(8):853-855. doi:10.1001/jama.2015.413
Comment & Response

Assessing the Benefit of Vascular Closure Devices After Femoral Artery Puncture

Abstract Full Text
JAMA. 2015;313(8):855. doi:10.1001/jama.2015.421

Assessing the Benefit of Vascular Closure Devices After Femoral Artery Puncture—Reply

Abstract Full Text
JAMA. 2015;313(8):855-856. doi:10.1001/jama.2015.427

Male Body Image and Weight-Related Disorders

Abstract Full Text
JAMA. 2015;313(8):856. doi:10.1001/jama.2015.424

Male Body Image and Weight-Related Disorders—Reply

Abstract Full Text
JAMA. 2015;313(8):856-857. doi:10.1001/jama.2015.433

Alternative Pricing Strategies for Cancer Drugs

Abstract Full Text
JAMA. 2015;313(8):857. doi:10.1001/jama.2014.17814

Alternative Pricing Strategies for Cancer Drugs—Reply

Abstract Full Text
JAMA. 2015;313(8):858. doi:10.1001/jama.2014.17817
Correction

Inconsistent Units of Measure

Abstract Full Text
free access
JAMA. 2015;313(8):858. doi:10.1001/jama.2015.334
Medical News & Perspectives

Efforts Seek to Develop Systematic Ways to Objectively Assess Surgeons’ Skills

Abstract Full Text
JAMA. 2015;313(8):782-784. doi:10.1001/jama.2015.233
The JAMA Forum

On Fear, Distrust, and Ebola

Abstract Full Text
free access
JAMA. 2015;313(8):784. doi:10.1001/jama.2015.346
Clinical Trials Update

Glaucoma Drug Significantly Slows the Progression of Vision Loss

Abstract Full Text
JAMA. 2015;313(8):786. doi:10.1001/jama.2015.0721

Trials Will Assess Effect of Flexible Hours for Trainees

Abstract Full Text
JAMA. 2015;313(8):786. doi:10.1001/jama.2015.0723

Progesterone Offers No Benefits in Traumatic Brain Injury

Abstract Full Text
JAMA. 2015;313(8):786. doi:10.1001/jama.2015.236
Health Agencies Update

Proposed Rule Seeks to Safeguard Against Phased-Out Chemicals

Abstract Full Text
JAMA. 2015;313(8):785. doi:10.1001/jama.2015.0746

Officials Strive to Help Consumers Shop for Health Insurance Benefits

Abstract Full Text
JAMA. 2015;313(8):785. doi:10.1001/jama.2015.0748

Electric Stimulation Device Approved to Treat Obesity

Abstract Full Text
JAMA. 2015;313(8):785. doi:10.1001/jama.2015.234
News From the Centers for Disease Control and Prevention

Toxic Puffer Fish Species Illegally Imported to United States

Abstract Full Text
JAMA. 2015;313(8):787. doi:10.1001/jama.2015.384

Cholesterol-Lowering Drugs Taken by 28% of US Population

Abstract Full Text
JAMA. 2015;313(8):787. doi:10.1001/jama.2015.387
The Art of JAMA

By the RiverEdward W. Redfield

Abstract Full Text
JAMA. 2015;313(8):778-779. doi:10.1001/jama.2014.11597
Poetry and Medicine

compline

Abstract Full Text
JAMA. 2015;313(8):860. doi:10.1001/jama.2014.14627
JAMA Revisited

The Effects of Weather on Pain, Comfort and Efficiency

Abstract Full Text
JAMA. 2015;313(8):861. doi:10.1001/jama.2014.11604
JAMA Patient Page

Advance Directives

Abstract Full Text
free access
JAMA. 2015;313(8):868. doi:10.1001/jama.2015.133
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2015;313(8):775-776. doi:10.1001/jama.2014.11596
×